| Description | Valziflocept (BAX1810; TAK-752) is a recombinant soluble human FcγRIIb receptor designed to act as a "decoy" or "scavenger" by targeting Fc and FcγR, binding and neutralizing pathogenic IgG. Its utility lies in mitigating the impact of autoimmune diseases, making it a focus in systemic lupus erythematosus (SLE) research [1]. |
| Synonyms | BAX1810, TAK-752 |
| molecular weight | N/A |
| CAS | 1804910-11-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years | Shipping with blue ice. |